Synthomer (LON:SYNT) Hits New 52-Week Low - Is It Time to Sell?

Synthomer plc (LON:SYNT) has recently witnessed its share price decline to a new 52-week low during Friday's mid-day trading session. The stock dropped to as low as GBX 128 ($1.58) and was last noted at GBX 140.20 ($1.73) with 598,533 shares traded. This shows a decrease from its previous close at GBX 131 ($1.62).

Analysis and New Price Targets

Several analysts have provided updates on Synthomer shares. Canaccord Genuity Group has revised their target price for Synthomer shares, lowering it from GBX 300 ($3.71) to GBX 275 ($3.40), while maintaining a "buy" rating in a report dated October 4th. Similarly, Berenberg Bank adjusted their price target down from GBX 265 ($3.27) to GBX 230 ($2.84) and also rated the stock as a "buy" in their publication dated January 6th.

Current Stock Performance Insights

Synthomer is currently showing a current ratio of 1.90, a quick ratio of 0.97, and a debt-to-equity ratio of 77.42. The stock's 50-day moving average stands at GBX 157.94, while its 200-day moving average is noted at GBX 199.73. The company boasts a market capitalization of £229.33 million, a negative P/E ratio of -229.84, a negative PEG ratio of -0.17, and a beta of 1.79, indicating its volatility in the market.

Understanding Synthomer's Business Model

Synthomer plc operates as a specialized chemicals company both in the UK and globally. The company is structured into five main segments: Performance Elastomers, Functional Solutions, Industrial Specialties, Acrylate Monomers, and Adhesive Technologies. It produces a variety of products, including adhesives for packaging, specialty tapes, and various coatings for architecture and other applications.

Should You Invest in Synthomer Right Now?

Before making a decision on whether to invest in Synthomer, it's wise to be informed of market opinions. Currently, while analysts assign a "Moderate Buy" rating to the stock, other top-rated analysts have identified five alternative stocks which they recommend as potentially better investment opportunities.

If you're considering investing in Synthomer, it's crucial to weigh both the risks and potential rewards. Staying informed can help to make a more accurate decision regarding your investment strategy.

stocks, trading, analysis